Schertz Bergmann Rechtsanwälte: Alexander Zverev
As lawyers for Alexander Zverev, we declare on behalf of our client that the criminal proceedings under file number 250 Cs 184/23 have been dropped.
The criminal proceedings against Alexander Zverev were dropped and the case was terminated today by the court with the consent of the public prosecutor's office, Ms. Brenda Patea as joint plaintiff and Alexander Zverev's defence lawyer. The penalty order is now groundless.
Alexander Zverev has agreed to this discontinuation via his defense lawyer, solely in order to shorten the proceedings - above all in the interests of their child. Alexander Zverev is considered innocent. The dismissal does not constitute a finding of guilt or an admission of guilt. The legal presumption of innocence remains unaffected.
Dr. Anna Sophie Heuchemer (Schertz Bergmann Attorneys at law)
Katharina Dierlamm (Dierlamm Attorneys at law)
Pressekontakt
Schertz Bergmann Rechtsanwälte PartG mbB
Kurfürstendamm 53
10707 Berlin
Tel.: 030 88 00 150
E-Mail:cs@schertz-bergmann.de
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
EMD: Group of leading Polish retailers intends to join EMD, Europe’s leading buying and marketing group18.7.2025 14:00:00 CEST | Press release
EMD-Membership brings new sourcing opportunities for Grupa Eurocash, Grupa Chorten and Netto Strong presence in Poland strengthens EMD’s international market position
Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available16.7.2025 12:00:23 CEST | Press release
(Berlin, Germany) – ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the end of 2024 there were 17.041 pharmacies in Germany, which is the lowest number since the end of the 1970s. One of the main reasons for the increasing number of pharmacy closures is the economic difficulties many pharmacies are facing. Since the pharmacy remuneration has not been elevated in the past 12 years, around 25 percent of German pharmacies have earnings below 75.000 Euros a year. Around 7 percent of German pharmacies made losses in 2024. Those and other relevant facts and figures are shown on more than 130 pages in a revamped design of the new Statistical Yearbook – with several features that make the content easie
FEV Group: Generative AI accelerates homologation: FEV simplifies country-specific type approval processes10.7.2025 11:23:00 CEST | Press release
Aachen – Vehicle development doesn’t end with technical readiness: The road to global market launches is only complete once homologation has been successfully achieved. The increasing complexity of national regulations poses growing challenges to OEMs and suppliers. FEV addresses these with an innovative, AI-based approach: The company-wide used ‘FEV GenAI Hub’ significantly simplifies and accelerates the analysis of regulatory requirements across different global markets, offering time and cost savings that can provide customers with a decisive competitive edge.
Green: Innovation from Switzerland: New pump drive developed by Green’s Andrea Luigi Campomilla providing more efficiency in data center cooling8.7.2025 09:38:05 CEST | Press release
Andrea Luigi Campomilla, Green’s Chief Operating Officer and Chief Engineer, is commissioning a newly developed pump drive. The results are promising.
Intuitive Surgical Deutschland GmbH: Intuitive’s da Vinci 5 Surgical System Receives CE Mark2.7.2025 09:55:29 CEST | Press release
Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom